ArticlePloS one2024

Upregulation of Metrnl improves diabetic kidney disease by inhibiting the TGF-β1/Smads signaling pathway: A potential therapeutic target.

Lu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.